Elevated circulating levels of tumor necrosis factor in patients with mitral valve disease and ventricular septum defect

被引：3
作者：
Sato, Y
Takatsu, Y
Ito, H
Kataoka, K
Takeuchi, Y
Matsumori, A
机构：
[1] Division of Cardiology, Department of Internal Medicine, Hyogo Prefectural Amagasaki Hospital, Amagasaki, Hyogo 660
[2] Dept. of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto 606
来源：
HEART AND VESSELS | 1996年 / 11卷 / 04期
关键词：
tumor necrosis factor; cytokine; heart failure; mitral valve disease;
D O I：
10.1007/BF02559996
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Elevated levels of circulating tumor necrosis factor (TNF)-alpha have been reported in patients with decreased left ventricular ejection fraction. Also, TNF has been reported to depress myocardial contractility. In our previous study, no correlation was found between the plasma level of TNF and clinical parameters in patients with cardiomyopathy. In the present study, we detected elevated levels of circulating TNF-alpha in 5 out of 15 patients with mitral valve disease and in 1 patient with ventricular septal defect whose left ventricular ejection fraction was within the normal range. The levels of TNF-alpha were not correlated with any hemodynamic parameters. Further studies are necessary to clarify the mechanisms of the regulation and effects of TNF-alpha in patients with chronic heart failure.
引用
收藏
页码：218 / 220
页数：3
相关论文
共 11 条
[1]  
Fick A., 1870, SITZUNGSB PHYS MED G, V2, P16
[2]   NEGATIVE INOTROPIC EFFECTS OF CYTOKINES ON THE HEART MEDIATED BY NITRIC-OXIDE [J].
FINKEL, MS ;
ODDIS, CV ;
JACOB, TD ;
WATKINS, SC ;
HATTLER, BG ;
SIMMONS, RL .
SCIENCE, 1992, 257 (5068) :387-389
[3]   HYDRAULIC FORMULA FOR CALCULATION OF THE AREA OF THE STENOTIC MITRAL VALVE, OTHER CARDIAC VALVES, AND CENTRAL CIRCULATORY SHUNTS .1. [J].
GORLIN, R ;
GORLIN, SG .
AMERICAN HEART JOURNAL, 1951, 41 (01) :1-29
[4]   INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR INHIBIT CARDIAC MYOCYTE BETA-ADRENERGIC RESPONSIVENESS [J].
GULICK, T ;
CHUNG, MK ;
PIEPER, SJ ;
LANGE, LG ;
SCHREINER, GF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (17) :6753-6757
[5]  
HEGEWISCH S, 1990, LANCET, V336, P294
[6]   PATHOPHYSIOLOGICAL CORRELATES OF INCREASED SERUM TUMOR-NECROSIS-FACTOR IN PATIENTS WITH CONGESTIVE-HEART-FAILURE - RELATION TO NITRIC OXIDE-DEPENDENT VASODILATION IN THE FOREARM CIRCULATION [J].
KATZ, SD ;
RAO, R ;
BERMAN, JW ;
SCHWARZ, M ;
DEMOPOULOS, L ;
BIJOU, R ;
LEJEMTEL, TH .
CIRCULATION, 1994, 90 (01) :12-16
[7]   ELEVATED CIRCULATING LEVELS OF TUMOR-NECROSIS-FACTOR IN SEVERE CHRONIC HEART-FAILURE [J].
LEVINE, B ;
KALMAN, J ;
MAYER, L ;
FILLIT, HM ;
PACKER, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (04) :236-241
[8]  
MATSUMORI A, 1994, BRIT HEART J, V72, P561
[9]  
MCMURRAY J, 1991, BRIT HEART J, V66, P356
[10]  
PAGNI FD, 1992, J CLIN INVEST, V90, P389
12